ISSN (Print):
ISSN (Online):
Download PDF Flyer

Drug Metabolism and Bioanalysis Letters

(Formerly Drug Metabolism Letters) Limited Time Complementary OA Offer Papers submitted on or before December 31st, 2024, will be published as Promotional Open Access

Indexed in: Scopus, MEDLINE/PubMed, Cabell's Directory/Journalytics... View all

Volume 17 , Issues 3, 2024

Back Journal Home

Institutional Members

Aims & Scope

Drug Metabolism and Bioanalysis Letters aims to publish letters, original research articles, mini-reviews, thematic issues based on mini-reviews and letters, commentaries, technical notes, and drug clinical trial studies on major advances in all areas of drug metabolism and bioanalysis.

In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; bioactivation; recent developments for the identification of drug metabolites, reactive intermediate, and glutathione conjugates. LC/MS and other key detection methods, including ligand binding assays, sample preparation, chromatography and separation sciences, method development and validation with applications in drug and metabolite assays, pharmacokinetic/toxicokinetic assays, biomarker assays, immunogenicity assays, diagnostic assays.

Archived in
© 2024 Bentham Science Publishers | Privacy Policy